This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Apicomplexan Therapeutics, LLC, University of Strathclyde. Active years: 2004-2011.
Company Filing History:
Years Active: 2004-2011
Title: Fiona Roberts: Innovator in Antimicrobial Compounds
Introduction
Fiona Roberts is a distinguished inventor based in Glasgow, GB. She has made significant contributions to the field of antimicrobial research, holding 2 patents that focus on innovative compounds and diagnostic reagents.
Latest Patents
Her latest patents include groundbreaking work on antimicrobial compounds that modulate the shikimate pathway and related pathways in members of the Amoebida Order. These compounds are particularly useful in the treatment or prevention of diseases caused by these organisms. Additionally, she has developed antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components. This invention utilizes chorismate synthase, a component of plant-like metabolic pathways, to create compositions that interfere with the growth and survival of Apicomplexan parasites.
Career Highlights
Fiona has worked with notable organizations such as Apicomplexan Therapeutics, LLC and the University of Strathclyde. Her work has been pivotal in advancing the understanding and treatment of diseases associated with Apicomplexan parasites.
Collaborations
Throughout her career, Fiona has collaborated with esteemed colleagues, including Craig Roberts and Rima McLeod. These partnerships have further enriched her research and contributions to the field.
Conclusion
Fiona Roberts stands out as an innovative inventor whose work in antimicrobial compounds and diagnostic reagents has the potential to significantly impact public health. Her contributions continue to pave the way for advancements in the treatment of diseases caused by Apicomplexan parasites.